XML 84 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1

Revenues (Tables)

12 Months Ended

Dec. 31, 2021

Revenues [Abstract]

Schedule of net product revenues by product

The Company’s net product revenues consisted of the following for the years ended December 31:

						2021						2020						2019
Products:
Kristalose						$	15,993,658					$	15,567,562					$	12,895,120
Vibativ						11,704,062						10,870,990						8,691,550
Caldolor						4,970,301						5,336,943						5,222,282
Acetadote						850,993						1,874,206						3,824,449
Omeclamox-Pak						(388,657)						257,088						837,829
Vaprisol						1,859,581						1,077,227						936,615
RediTrex						55,321						856,657						—
Total net product revenues						$	35,045,259					$	35,840,673					$	32,407,845

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenuesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration